Nexalin Technology Shares Are Trading Higher After the Company Announced Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific Journal 'Brain Stimulation'
Nexalin 科技公司宣佈在《Brain Stimulation》頂尖學術期刊上發表了抑鬱症臨床試驗數據和臨床試驗結果後，公司股價上漲。